Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-386841

RxSight, Inc. · RXST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mark Wilterding
Officer — Chief Financial Officer
Period of report
Sep 5, 2026
Accepted (ET)
Sep 9, 2026 · 8:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001111485

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2,F1$10.09Sep 5, 2026D258,770D—Jan 11, 2036Common Stock258,7700D
Stock Option (right to buy)F2,F3$6.375Sep 5, 2026A258,770A—Sep 4, 2033Common Stock258,770258,770D

Explanation of responses